SCHEMBL5834618

SCHEMBL5834618

CCCCc1ccc(OCCCCCCBr)cc1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.55
▸ USP2 O75604 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ CASP1 P29466 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ SLCO1B3 Q9NPD5 1/20 0.55
▸ SLCO1B1 Q9Y6L6 1/20 0.55
▸ NR5A1 Q13285 1/20 0.51
▸ TP53 P04637 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ PLA2G4B P0C869 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9258093 1.00 MEN1 (0.55) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL9258412 0.98 MEN1 (0.53) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL10806879 0.95 MEN1 (0.61) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL8076076 0.95 MEN1 (0.60) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL8076106 0.95 MEN1 (0.60) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL8072876 0.95 MEN1 (0.60) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL8076372 0.95 MEN1 (0.60) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL8072244 0.95 MEN1 (0.60) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL8070971 0.95 MEN1 (0.60) MEN1USP2ALDH1A1LMNACYP3A4
SCHEMBL8078024 0.93 LMNA (0.58) MEN1USP2ALDH1A1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7112701-B2 Process for the manufacture of 4-(6-bromohexyloxy)-butylbenzene BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-09-26 — — US claimed
EP-1483226-B1 IMPROVED METHOD FOR THE PRODUCTION OF 4-(6-BROMOHEXYLOXY) BUTYLBENZENE BOEHRINGER INGELHEIM PHARMA (DE) 2005-09-07 — — EP claimed
US-20050113608-A1 Process for the manufacture of 4-(6-bromohexyloxy)-butylbenzene BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-05-26 — — US claimed
US-6835857-B2 Process for the manufacture of 4-(6-bromohexyloxy)-butylbenzene BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-12-28 — — US claimed
US-20030171620-A1 Process for the manufacture of 4-(6-bromohexyloxy)-butylbenzene BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-09-11 — — US claimed
CN-119241363-A Treprostinil derivative, and preparation method and application thereof 长风药业(香港)有限公司 2025-01-03 — — CN disclosed
US-7112701-B2 Process for the manufacture of 4-(6-bromohexyloxy)-butylbenzene BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-09-26 — — US disclosed
US-7112701-B2 Process for the manufacture of 4-(6-bromohexyloxy)-butylbenzene BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-09-26 — — US disclosed
US-7112701-B2 Process for the manufacture of 4-(6-bromohexyloxy)-butylbenzene BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-09-26 — — US disclosed
EP-1483226-B1 IMPROVED METHOD FOR THE PRODUCTION OF 4-(6-BROMOHEXYLOXY) BUTYLBENZENE BOEHRINGER INGELHEIM PHARMA (DE) 2005-09-07 — — EP disclosed
EP-1483226-B1 IMPROVED METHOD FOR THE PRODUCTION OF 4-(6-BROMOHEXYLOXY) BUTYLBENZENE BOEHRINGER INGELHEIM PHARMA (DE) 2005-09-07 — — EP disclosed
US-20050113608-A1 Process for the manufacture of 4-(6-bromohexyloxy)-butylbenzene BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-05-26 — — US disclosed
EP-1483226-A1 IMPROVED METHOD FOR THE PRODUCTION OF 4-(6-BROMOHEXYLOXY) BUTYLBENZENE Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2004-12-08 — — EP disclosed
EP-1483226-A1 IMPROVED METHOD FOR THE PRODUCTION OF 4-(6-BROMOHEXYLOXY) BUTYLBENZENE Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2004-12-08 — — EP disclosed
WO-2003074458-A1 IMPROVED METHOD FOR THE PRODUCTION OF 4-(6-BROMOHEXYLOXY) BUTYLBENZENE BOEHRINGER INGELHEIM PHARMA GMBH & CO KG (DE) 2003-09-12 — — WO disclosed
WO-2003074458-A1 IMPROVED METHOD FOR THE PRODUCTION OF 4-(6-BROMOHEXYLOXY) BUTYLBENZENE BOEHRINGER INGELHEIM PHARMA GMBH & CO KG (DE) 2003-09-12 — — WO disclosed
US-20030171620-A1 Process for the manufacture of 4-(6-bromohexyloxy)-butylbenzene BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-09-11 — — US disclosed
US-20030171620-A1 Process for the manufacture of 4-(6-bromohexyloxy)-butylbenzene BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-09-11 — — US disclosed
US-20030171620-A1 Process for the manufacture of 4-(6-bromohexyloxy)-butylbenzene BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-09-11 — — US disclosed
WO-1995019336-A1 PHENYL ETHANOL AMINE ETHERS AND USES THEREOF AS β-ADRENO-RECEPTOR AGONISTS IOVIS BIOMEDICAL AND PHARMACEUTICAL CONSULTANTS (NL) 1995-07-20 — — WO disclosed
Send feedback